Font Size: a A A
Keyword [C225]
Result: 1 - 16 | Page: 1 of 1
1. Neuroprotective Effect And Molecular Mechanism Of Inhibiting Epidermal Growth Factor Receptor Signaling Against Ischemia-reperfusion Injury
2. The Effect Of Mabs C225 In Combination With Cytotoxic Drugs Is Sequence-dependent In Colon And NSCLC Cancer Cells Lines
3. Antitumor Activity Of C225 In Combination With Docetaxel In Human Gastric Carcinima Cell Lines MGC803 And BGC823 In Vitro
4. Antitumor Activities Of Cetuximab In Combination With Radiotherapy In Human Gastric Carcinoma Cell Lines MGC803 And BGC823
5. Anti-tumor Activity And Pre-clinical Pharmacokinetic Study Of Anti-epidermal Growth Factor Receptor Monoclonal Antibody C225
6. Study On Magnetic Resonance Immunity Imaging Of Argeted Nano Contrast Medium C225-USPIO To Nasopharyngeal Carcinoma CNE1 Cells With High-expressed EGFR
7. Study On Magnetic Resonance Immunity Imaging Of Argeted Nano Contrast Medium C225-uspio To Nasopharyngeal Carcinoma Cne1 Cells With High-expressed Egfr
8. In-vitro Test Of Targeted Nano Magnetic Resonance Contrast Medium C225-USPIO Against EGFR
9. The Research On Mri Of Contrast Agent Nanoparticles C225-USPIO Marker Targeting To The Nasopharyngeal Carcinoma Xenograft In Nude Mice
10. Development Of Colloidal Au-enhanced SPR Technology For Quantitation Of Antibody Drug Of C225
11. The Therapeutic Effect Of C225/p5HRE-cfosp-iNOS-IFNG Based On Magnetic Albumin Nanospheres For Lung Cancer
12. Experimental Research On EGFR Inhibitors To Newborn Rats Brain Injury Caused By Intrauterine Infection
13. Enhancement Of Radiation Effect On SMMC-7721 Cells By C225-GNPs And Its Potential Michanisms
14. Silencing N-acetylglucosaminyltransferase V Enhances Cetuximab-induced Radiosensitivity Of Nasopharyngeal Carcinoma Through Glycosylation On EGFR
15. Preparation Of Immunomagnetic Composite Particles By Co-conjugated Doxorubicin And C225 As A Novel Targeted Nanocarrier For Non-small Cell Lung Cancer
16. Combined use of multiple monoclonal antibodies targeting epidermal growth factor receptor for improved cancer therapeutics
  <<First  <Prev  Next>  Last>>  Jump to